PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419046
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419046
Incontinence and ostomy care products Market size was valued at USD 17,028.4 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.
The market for incontinence and ostomy care products encompasses a range of items designed to assist individuals dealing with incontinence issues or those who have undergone ostomy procedures. These products include absorbent pads, adult diapers, catheters, ostomy bags, and accessories aimed at managing urinary or fecal incontinence and aiding individuals with stomas due to surgeries. The demand for these products is predominantly driven by the rising prevalence of conditions such as urinary incontinence, fecal incontinence, and an increasing number of ostomy procedures performed worldwide. Improved product designs focused on comfort, discretion, and advanced materials that ensure better absorption and reduced skin irritation also contribute to the growth of this market.
The market's growth is primarily driven by elevated prevalence of inflammatory bowel diseases (IBD), a rising occurrence of urinary incontinence (UI) associated with conditions like ulcerative colitis or Crohn's disease, and colorectal cancer, leading to a surge in ostomy surgeries. According to the July 2021 WHO updates, there is an anticipated global increase of approximately 70% in colorectal cancer cases by 2030. GLOBOCAN statistics further highlight colorectal cancer as the fourth most prevalent cancer type in Germany, recording about 57,528 new cases in 2021. Similarly, GLOBOCAN's 2020 data revealed 33,815 new colon cancer cases and 11,951 deaths due to the disease in the United Kingdom, augmenting the demand for ostomy procedures and devices, thus propelling market growth in the foreseeable future. Moreover, a study featured in the April 2022 edition of Female Pelvic Medicine & Reconstructive Surgery indicated that 61.8% of women experienced UI, amounting to 78,297,094 adult women in the United States in 2021, with 32.4% reporting symptoms monthly. Among those affected, 37.5% had stress urinary incontinence, 22.0% faced urgency urinary incontinence, 31.3% had mixed symptoms, and 9.2% experienced unspecified incontinence. Consequently, the considerable burden of UI among women is poised to drive increased demand for incontinence products, thereby fostering market growth in the forecast period.
The Global Incontinence and ostomy care products Market is segmented on the basis of Product type, Application, Ostomy Bags, and Region.
The market is divided into two categories based on product type: Ostomy Care Product and incontinence care products. The incontinence care products category held sway in the market, commanding the largest revenue share in 2022, and it is poised to exhibit the most rapid growth in the forecast period. This prominence is attributed to heightened usage, the increasing preference for disposable adult diapers, the expanding elderly population, and the rising prevalence of bladder-related ailments like cystitis, urinary incontinence, and overactive bladder. Furthermore, the market's trajectory is justified by the emergence of innovative, tailored products aimed at enhancing ease of use and comfort, coupled with the gradual destigmatization of items such as adult diapers. A case in point is the May 2023 launch of UltraThinz by Friends Adult Diapers, a brand under Nobel Hygiene Pvt Ltd, introducing disposable slim diapers tailored for individuals experiencing mild incontinence, featuring separate versions for both men and women.
The market is divided into three categories based on ostomy bag: colostomy bag, and Ileostomy Bags and Urostomy Bags.Colostomy bag dominated the market in 2022., Also referred to as a stoma or ostomy bag, serves as a small, water-resistant container utilized for collecting bodily waste. During a surgical procedure called a colostomy, a stoma or ostomy is created, establishing an opening between the large intestine (colon) and the abdominal wall. This newly formed connection allows waste materials to exit the body through this opening in the abdominal wall instead of the usual passage through the colon, rectum, and anus. Waste, including stool, is directed into the pouch-like colostomy bag, facilitating periodic emptying. The escalating demand for these bags has stemmed from the rising occurrence of inflammatory bowel diseases (IBD). Notably, a study published in the BMC Journal in August 2021 revealed that in the United Kingdom, the incidence rates for inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) stood at 28.6, 10.2, and 15.7 per 100,000 population, respectively, in 2021. Such elevated disease incidences are anticipated to be a significant driver propelling market expansion.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Companies operating in the incontinence and ostomy care products market deploy various strategies to maintain competitiveness and foster growth. Some key strategies include continuous innovation in product development, with a focus on enhancing product quality, comfort, and effectiveness. These companies often invest in research and development to introduce advanced materials and technologies that improve the performance and comfort of their products. Moreover, strategic mergers, acquisitions, and partnerships with healthcare providers or Ostomy Bags networks are common to expand market reach and access to a broader customer base. Additionally, effective marketing campaigns, emphasizing product benefits and addressing consumer needs, are pivotal in maintaining and growing market shares. Ensuring regulatory compliance, cost-effective manufacturing, and catering to the specific needs of different consumer segments are also essential strategies adopted by companies in this sector to succeed in a competitive market landscape.
In December 2022, Axonics, Inc., a worldwide medical technology enterprise dedicated to innovating and marketing pioneering products aimed at addressing bladder and bowel dysfunction, disclosed that Health Canada had granted approval for the company's latest rechargeable sacral neuromodulation system, the fourth generation in its lineup.
The scope of this report covers the market by its major segments, which include as follows: